Related Experiment Video
Updated: Jun 28, 2025

07:32
Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
4.0K
Causal association between gut microbiota and hyperemesis gravidarum: a two-sample Mendelian randomization study
Dinglin Xu1, Liang Zhang2, Jianwei Zhang2
1The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in Microbiology
|April 18, 2024
Summary
Mendelian randomization analysis suggests specific gut bacteria influence hyperemesis gravidarum (HG) risk. Targeting the gut microbiota may offer a novel therapeutic approach for HG.
Area of Science:
- Microbiology
- Genetics
- Obstetrics
Background:
- Observational studies suggest a link between gut microbiota (GM) and hyperemesis gravidarum (HG).
- The causal relationship between GM and HG remains unclear.
- This study investigates the causal role of GM in HG development.
Purpose of the Study:
- To infer causal relationships between gut microbiota composition and hyperemesis gravidarum risk.
- To identify specific bacterial taxa causally associated with HG.
- To explore potential therapeutic targets for HG by modulating the gut microbiota.
Main Methods:
- Mendelian randomization (MR) analysis using summary statistics from genome-wide association studies (GWAS).
- Inverse-variance weighted MR for causal inference.
- Sensitivity analyses and reverse MR to assess robustness and causality.
Main Results:
- Several bacterial genera (e.g., *Defluviitaleaceae UCG011*, *Ruminococcus1*, *Ruminococcus2*, *Turicibacter*) and the phylum *Verrucomicrobiota* were positively associated with HG risk.
- The genus *Coprococcus2* showed a decreased association with HG risk.
- Sensitivity analyses confirmed the reliability of the GM-HG association, with no evidence of reverse causality.
Conclusions:
- Mendelian randomization provides novel insights into the causal links between gut microbiota and HG.
- Specific gut microbial taxa are causally associated with HG risk.
- Modulating the gut microbiota presents a potential therapeutic strategy for managing HG.

